GlassScriptPhysician profile
Alfred J Bilik
NPI 1902993496
$4,673.75
in general payments reported to CMS, 2019-2025
41 companies · $1,507 in 2025
The $1,507 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $66.74 · 2021: $367 · 2022: $481 · 2023: $637 · 2024: $1,055 · 2025: $1,507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,768 · Travel and Lodging: $397 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,767.65 |
| Travel and Lodging | $396.96 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $885.56 | 2024-2025 | Aquabeam System |
| Coloplast Corp | $515.99 | 2020-2025 | Titan, Speedicath |
| Astellas Pharma US INC | $303.82 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $277.94 | 2022-2025 | Botox |
| Boston Scientific Corporation | $241.31 | 2019-2024 | Spaceoar Vue System - 10ml, Rezum Generator, Spectra |
| Intuitive Surgical, INC. | $157.36 | 2021-2023 | Da Vinci Surgical System |
| Sumitomo Pharma America, INC. | $157.30 | 2023-2025 | Gemtesa, Orgovyx |
| Endo USA, INC. | $150.80 | 2024-2025 | Xiaflex, Aveed, Edex |
| Janssen Biotech, INC. | $145.85 | 2019-2025 | Erleada |
| Teleflex LLC | $142.88 | 2023-2025 | Urolift, Barrigel |
| Caldera Medical, INC | $141.56 | 2021 | |
| 180 Medical, INC. | $133.00 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $129.23 | 2019-2023 | Xiaflex, Aveed, Edex |
| Axonics, INC. | $123.56 | 2023-2024 | Axonics, Bulkamid |
| Novartis Pharmaceuticals Corporation | $119.27 | 2022-2025 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $115.91 | 2024-2025 | Eligard |
| Ferring Pharmaceuticals INC. | $93.10 | 2025 | Adstiladrin |
| Ethicon US, LLC | $92.10 | 2019 | |
| Laborie Medical Technologies Corp. | $56.60 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Allergan, INC. | $55.86 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $52.52 | 2022 | |
| Dendreon Pharmaceuticals LLC | $50.69 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $50.63 | 2019 | |
| Pfizer INC. | $46.94 | 2019-2024 | |
| C. R. Bard, INC. & Subsidiaries | $46.24 | 2022 | |
| Bioprotect Medical, INC. | $46.09 | 2024-2025 | Bioprotect Balloon Implant System |
| Urogen Pharma, INC. | $43.79 | 2023-2025 | Jelmyto |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Myovant Sciences INC. | $31.36 | 2022 | |
| Merck Sharp & Dohme LLC | $30.84 | 2019 | |
| Olympus America INC. | $26.04 | 2023 | Itind System |
| Aytu Biopharma, INC. | $22.78 | 2019 | |
| Coopersurgical, INC. | $21.53 | 2024 | Wallach Cryosurgical Equipment |
| Bluewind Medical | $19.63 | 2025 | |
| Immunitybio, INC. | $19.15 | 2025 | |
| Medtronic, INC. | $19.02 | 2022 | |
| Urovant Sciences INC | $17.18 | 2022 | |
| Angiodynamics, INC. | $16.99 | 2023 | Nanoknife |
| Antares Pharma, INC. | $16.59 | 2024 | Xyosted |
| Baxter Healthcare | $12.68 | 2019 | |
| Edap Technomed INC | $9.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Bilik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.